Roth Capital Initiates Biodel At Buy

Roth Capital initiated coverage on Biodel Inc BIOD with a Buy rating. The target price for Biodel is set to $5. Biodel shares have dropped 47.93 percent over the past 52 weeks, while the S&P 500 index has surged 12.61 percent in the same period. Biodel shares closed at $1.13 on Friday.